Prof. Eyal Banin | Hadassah International

Science fiction? Male and Female Stem Cells Derived from the Same Person with the Same Genetic Code

The following article was originally published in the Hadassah International 2022 Year In Review. To access the complete Hadassah International 2022 Year in Review – click here: Cure. Innovation. Humanity. “For…

Hadassah Hospital

Hadassah Stem Cell Breakthrough to Power Roche International Development of Macular Degeneration Treatment

...More than a Hospital

Eye-Opening Advances: Hadassah Transports Us Into the Future of Eye Care

Winter Live Series

NOW I SEE YOU

Ophthalmology

Hadassah Physicians, Jointly with German and Swiss Colleagues, Identify Severe Eye Disease Only Seen in Mice Before

Macular Degeneration

Safety Success in Hadassah AMD Stem Cell Trial to be Presented at International Conference

Macular Degeneration

Successful Start to Hadassah’s Unique Stem Cell Clinical Trial to Treat Major Cause of Blindness

Macular Degeneration

First Patient Receives Stem Cell-based Therapy for Macular Degeneration at Hadassah

Macular Degeneration

Clinical Trials for Macular Degeneration start as Cell Cure Receives Major Grant to Further Develop Unique Treatment for AMD

Macular Degeneration

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

Macular Degeneration

Hadassah International

Science fiction? Male and Female Stem Cells Derived from the Same Person with the Same Genetic Code

Science fiction? Male and Female Stem Cells Derived from the Same Person with the Same Genetic Code

Hadassah Stem Cell Breakthrough to Power Roche International Development of Macular Degeneration Treatment

Eye-Opening Advances: Hadassah Transports Us Into the Future of Eye Care

NOW I SEE YOU

Hadassah Physicians, Jointly with German and Swiss Colleagues, Identify Severe Eye Disease Only Seen in Mice Before

Hadassah Stem Cell Pioneer Singled Out for Clinical Success

Safety Success in Hadassah AMD Stem Cell Trial to be Presented at International Conference

Successful Start to Hadassah’s Unique Stem Cell Clinical Trial to Treat Major Cause of Blindness

First Patient Receives Stem Cell-based Therapy for Macular Degeneration at Hadassah

Clinical Trials for Macular Degeneration start as Cell Cure Receives Major Grant to Further Develop Unique Treatment for AMD

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

Hadassah-Generated Stem Cell Treatment for Macular Degeneration to be Developed and Commercialized